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Abstract
Introduction: Crohn’s disease (CD) and ulcerative colitis (UC) are the two major forms of inflammatory bowel disease (IBD).
A high prevalence of Campylobacter concisus was previously detected in paediatric CD and adult UC. Currently, the
prevalence of C. concisus in adult CD and the preferential colonization sites of Campylobacter species in the human intestine
are unknown. In this study, we examined the prevalence of Campylobacter species in biopsies collected from multiple
anatomic sites of adult patients with IBD and controls.
Methods: Three hundred and one biopsies collected from ileum, caecum, descending colon and rectum of 28 patients IBD
(15 CD and 13 UC) and 33 controls were studied. Biopsies were used for DNA extraction and detection of Campylobacter
species by PCR-sequencing and Campylobacter cultivation.
Results: A significantly higher prevalence of C. concisus in colonic biopsies of patients with CD (53%) was detected as
compared with the controls (18%). Campylobacter genus-PCR positivity and C. concisus positivity in patients with UC were
85% and 77% respectively, being significantly higher than that in the controls (48% and 36%). C. concisus was more often
detected in descending colonic and rectal biopsies from patients with IBD in comparison to the controls. C. concisus was
isolated from patients with IBD.
Conclusion: The high intestinal prevalence of C. concisus in patients with IBD, particularly in the proximal large intestine,
suggests that future studies are needed to investigate the possible involvement of C. concisus in a subgroup of human IBD.
To our knowledge, this is the first report of the association between adult CD and C. concisus as well as the first study of the
preferential colonization sites of C. concisus in the human intestine.
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Introduction
Campylobacter species have been associated with various diseases
in both animals and humans [1]. Campylobacter jejuni and
Campylobacter coli are well established human pathogens, having
been associated with a number of clinical conditions such as
diarrhoea, abortion, septicaemia and Guillain-Barre syndrome [1].
Some other Campylobacter species including Campylobacter concisus
have been considered as emerging human pathogens [2].
C. concisus is a curved Gram negative bacterium; with a single
polar flagellum [3]. C. concisus was first isolated by Tanner et al in
1981 from human dental plague [4]. In a following-up study,
Macuch and Tanner reported a higher isolation rate of C. concisus
in patients at the initial stage of periodontitis in comparison to
individuals with healthy gums [5].
Lately, C. concisus has been considered as an emerging human
enteric pathogen [6]. Evidence that C. concisus may be an
important human enteric pathogen has come from a number of
recent studies reported that C. jejuni and C. concisus are the most
commonly isolated Campylobacter species from diarrheal stool
specimens [2,7,8,9]. However, when Engberg et al compared the
prevalence of C. concisus in 107 stool samples subjected to tests for
enteric pathogens and in 107 age/sex matched healthy controls,
they found that the prevalence of C. concisus in these two groups
was not significantly different [9]. Furthermore, they found that C.
concisus was more often isolated from children aged 0–9 years and
individuals aged over 60 years as compared with other age groups.
These results have led Engberg et al to conclude that C. concisus
should be considered as a commensal bacterium and this
bacterium may be an important opportunistic pathogen in
individuals with compromised or immature immune systems [9].
In addition to periodontal and diarrheal diseases, recently C.
concisus has been linked to inflammatory bowel disease (IBD). IBD
is a chronic inflammatory condition of the gastrointestinal tract,
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ulcerative colitis (UC). The inflammation in CD may occur
anywhere along the gastrointestinal tract, however in UC the
inflammation often occurs in colon and rectum [10]. The
aetiology of IBD is currently unknown. It is understood that a
complex interaction of a number of factors including host genetics,
environment, immune system and intestinal microflora contributes
to the development of IBD [10,11,12]. Despite strong evidence
that the intestinal microbial flora plays a key role in the
development of IBD, the exact causative agent (s) is still under
investigation [11].
Previously, we detected a significantly higher prevalence of C.
concisus by PCR in intestinal biopsies of children with CD (51%) as
compared with the controls (2%) and isolated a C. concisus strain
from intestinal biopsies of a child with CD [13]. In a later study,
we detected high prevalence of C. concisus in stool samples of
children with CD [14]. A recent study by Mukhopadhya et al
reported a significantly higher prevalence of C. concisus detected by
PCR in adult patients with UC as compared with the controls
[15].
To date, the prevalence of C. concisus in adult patients with CD
has not been investigated. Furthermore, no information is
available regarding whether Campylobacter species preferentially
colonize specific sites in the human intestine. In this study, we
examined the prevalence of Campylobacter species in biopsies
collected from four anatomic sites of intestines from adult
individuals with normal intestinal histology and patients with
IBD by PCR-sequencing and Campylobacter cultivation.
Materials and Methods
Ethics statement
Intestinal biopsies were obtained from colonoscopy procedures
carried out at the Prince of Wales Hospital and the St George
Hospital at Sydney, Australia. Ethics approval for this study was
granted by the Ethics Committees of the University of New South
Wales and the South East Sydney Area Health Service, Australia
(HREC 09237/SESIAHS 09/078 and HREC08335/SESIAHS
(CHN)07/48). Written informed consent was obtained from all
subjects in this study.
Study subjects and biopsy collection
Sixty-one study subjects, including 28 patients with IBD and 33
controls, were recruited from the Prince of Wales Hospital and the
St George Hospital at Sydney, Australia. Among the 28 patients
with IBD (15 CD and 13 UC), ten patients (six CD and four UC)
were relapsed cases and the remaining eighteen patients were
newly diagnosed IBD. Disease location and severity were scored
according to the Montreal criteria [16]. The controls, either
presenting with gastrointestinal symptoms including abdominal
pain and constipation or undertaking a screening colonoscopic
examination due to previous history of polyps or a family history of
colonic cancer, had no macroscopic or microscopic intestinal
inflammation.
Five biopsies were collected from each individual. In the case
where macroscopic inflammation was present, biopsies were
taken from the edge of the inflamed areas. Of the five biopsies
collected from each individual, four biopsies collected from each
of the four anatomic sites (ileum, caecum, descending colon and
rectum respectively) were used for DNA extraction and
detection of Campylobacter species by PCR. The additional
biopsy collected from caecum was used for Campylobacter
cultivation.
DNA extraction from intestinal biopsies
Freshly collected intestinal biopsies were directly placed into cell
lysis solution and DNA was extracted using the Puregene DNA
Extraction kit (Gentra, Minneapolis, USA) according to the
manufacturer’s instructions.
Detection of Campylobacter species in intestinal biopsies
by Campylobacter genus-PCR
To detect all Campylobacter species, DNA extracted from
intestinal biopsies were subjected to a nested Campylobacter genus-
PCR. Bacterial 16S rRNA gene was first amplified from 200 ng of
DNA extracted from intestinal biopsies using universal primers
F27 and R1496 [17]. The thermal cycling conditions were 94uC
for 10 minutes, followed by 35 cycles of 94uC for 10 seconds, 53uC
for 10 seconds and 72uC for 1 minute. The PCR reaction volume
was 25 ml. The PCR product was then purified using QIAquick
PCR purification kit (Qiagen, Hilden, Germany). The purified
PCR product (2 ml) was subjected to a Campylobacter genus-specific
PCR using primers C418 and C1228 designed by Linton et al [18].
The thermal cycling conditions for the Campylobacter genus-specific
PCR were 94uC for 5 minutes, followed by 35 cycles of 94uC for
30 seconds, 55uC for 30 seconds and 72uC for 30 seconds.
Campylobacter species identification
All positive PCR products were sequenced using the BigDyeTM
terminator chemistry (Applied Biosystems, Foster City, USA) and
the sequencing mixture was analysed on DNA sequence analyser
ABI3720 (Applied Biosystems, Foster City, USA). The obtained
sequences were compared to gene sequences of known bacterial
identities available in GenBank through the National Centre for
Biotechonology Information (NCBI website (http://www.ncbi.
nlm.nih.gov).
C. concisus specific PCR
Three samples which had mixed sequences in the Campylobacter
genus-PCR were subjected to a previously described C. concisus
PCR to examine if C. concisus was present [14]. For the C. concisus
PCR, DNA (50 ng) extracted from biopsies was subjected to the
Campylobacter genus-PCR, then 1 ml of the Campylobacter genus-PCR
product was subjected to C. concisus PCR as previously described
[14].
Cultivation of Campylobacter species from intestinal
biopsies
One caecal biopsy collected from each individual was subjected
to Campylobacter cultivation. The biopsy was spread on agar plates
prepared using blood agar base no 2 supplemented with 6% sterile
defibrinated horse blood, trimethoprim (10 mg/ml), and vanco-
mycin (10 mg/ml). The plates were incubated under microaero-
philic conditions generated by a Campylobacter gas generating
system (Oxoid Limited, Hampshire, United Kingdom) for two
days. A bacterial suspension was prepared from the culture plates
and filtered through a 0.6 mM filter membrane (Millipore,
Billerica, USA) onto a fresh agar plate and further incubated for
additional two days.
Candidate colonies were subjected to microscopic examination
of morphology, Gram staining, PCR targeting the 16S rRNA gene
using primers F27 and R1649 and sequencing of the PCR
products.
GenBank Sequence Submission
All 16S rRNA gene sequences of the PCR products were
submitted to GenBank.
Campylobacter Species and IBD
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Fisher’s exact test (two tailed) was used to compare the
prevalence of Campylobacter species in patients with IBD and
controls. Unpaired t test was used to compare the age of patients
and controls. Statistical analysis was performed using GraphPad
Prism 5 software (San Diego, CA).
Results
Clinical information of patients and controls
The average age of the patients with IBD and controls was
39613 and 45611 years old respectively. There were 12 male
(43%) patients with IBD and 13 male in controls (39%). The age
and sex between patients with IBD and controls were not
statistically different.
A total of 301 biopsies (165 biopsies from 33 controls and 136
biopsies from 28 patients with IBD) were collected from four
intestinal sites (ileum, caecum, descending colon and rectum) of
patients with IBD and controls. Ileal biopsies were not available
from two patients with CD, a caecal biopsy was not available from
one patient with CD and a rectal biopsy was not available from an
additional patient with CD. Both patients and controls did not
receive antibiotics one month prior to colonoscopy.
All controls had normal intestinal histology. The Montreal
classification of patients with IBD is summarized in Table 1.
Prevalence of Campylobacter species in biopsies
collected from different intestinal sites of individuals with
normal intestinal histology
To examine the possible preferential colonization sites of
Campylobacter species particularly C. concisus in the human intestine,
DNA samples extracted from biopsies collected from four
intestinal anatomic sites of 33 individuals with normal intestinal
histology were subjected to Campylobacter genus-PCR. Among the
33 individuals examined, 48% (16/33) were positive for Campylo-
bacter genus-PCR (an individual with at least one of the four
intestinal biopsies collected from ileum, caecum, descending colon
and rectum positive by the Campylobacter genus-PCR was
considered Campylobacter genus-PCR positive). Of the 16 individ-
uals who were positive by the Campylobacter genus-PCR, four
individuals had one biopsy positive and 12 individuals had 2–4
biopsies positive by the PCR. Campylobacter genus-PCR positive
rate in biopsies collected from ileum, caecum, colon and rectum
were 27% (9/33), 30% (10/33), 27% (9/33), rectum 27% (9/33)
respectively, with no statistical differences observed between sites.
Campylobacter genus-PCR positive rate in male was 42% (5/12);
with no statistical difference from that in females (52%, 11/21).
Sequencing of the positive PCR products yielded 503–766 bp
sequences. The obtained sequences were used for identification of
Campylobacter species. The similarities of 16S rRNA gene sequences
between the Campylobacter genus-PCR products and the known
Campylobacter species were 97%–100%. Five Campylobacter species
were identified from biopsies collected from individuals with
normal intestinal histology, including C. concisus, Campylobacter
showae, Campylobacter hominis, Campylobacter ureolyticus and Campylo-
bacter hyointestinalis. Among the 12 individuals who had multiple
biopsies positive for the Campylobacter genus-PCR, single Campylo-
bacter species was identified in eight individuals and two
Campylobacter species were identified in the remaining four
individuals.
Among the 33 individuals examined, 36% (12/33) of individuals
were positive for C. concisus, 6% (2/33) of individuals were positive
for C. showae, 9% (3/33) of individuals were positive for C. hominis,
6% (2/33) of individuals were positive for C. ureolyticus and 3% (1/
33) of individuals were positive for C. hyointestinalis. For an
individual to be classified as C. concisus positive, C. concisus had to be
identified in at least one of the four biopsies collected. The same
principle applied for the evaluation of the intestinal prevalence of
the other Campylobacter species in this study.
Campylobacter species detected in biopsies collected from the four
intestinal anatomic sites of individuals with normal histology is
shown in Table 2. Ileal, caecal and colonic biopsies showed similar
C. concisus positive rates and the rectum had a lower C. concisus
positive rate; however the difference was not statistically
significant. Given the low positive rate for the remaining four
Campylobacter species, no statistical analysis was applied to compare
the prevalence of these Campylobacter species in different sites of the
intestines (Table 2).
Comparison of intestinal prevalence of Campylobacter
species in patients with IBD and controls
The above 33 individuals with normal intestinal histology were
used as controls. Campylobacter genus-PCR positive rate in patients
with IBD was 82% (23/28), which was significantly higher than
that of the controls (48%, 16/33) (P,0.05). The Campylobacter
genus-PCR positive rate was 80% (12/15) in patients with CD and
Table 1. Montreal classification of patients with IBD
Montreal classification (CD) CD (n=15)
L1 7% (1/15)
L2 60% (9/15)
L3 33% (5/15)
Montreal classification (UC)-Extent UC (n=13)
Proctitis E1 8% (1/13)
Left sided UC E2 38% (5/13)
Extensive UC E3 54% (7/13)
Montreal classification (UC)-Severity UC (n=13)
Clinical remission S0 0
Mild UC S1 54% (7/13)
Moderate UC S2 46% (6/13)
Severe UC S3 0
doi:10.1371/journal.pone.0025417.t001
Table 2. Detection of Campylobacter species in biopsies
collected from four intestinal anatomic sites of individuals
(n=33) with normal intestinal histology by Campylobacter
genus-PCR and sequencing*.
Ileum Caecum Colon Rectum
C. concisus 21% (7/33) 18% (6/33) 18% (6/33) 9% (3/33)
C. showae 3% (1/33) 3% (1/33) 3% (1/33) 6% (2/33)
C. hominis 3% (1/33) 6% (2/33) 3% (1/33) 9% (3/33)
C. ureolyticus 0 0 3% (1/33) 3% (1/33)
C. hyointestinalis 0 3% (1/33) 0 0
*Four biopsies, one each from ileum, caecum, descending colon and rectum of
each individual, were examined. Identification of Campylobacter species was
based on 97–100% similarity of the sequences of PCR products (503–766 bp) to
the sequences of known Campylobacter species.
doi:10.1371/journal.pone.0025417.t002
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group and the controls being statistically significant (P,0.05) and
the difference between CD and controls being not statistically
significant (Figure 1).
The prevalence of different Campylobacter species in patients with
IBD and controls is shown in Table 3. Eight Campylobacter species
were identified in intestinal biopsies collected from patients with
IBD. C. concisus was detected in 68% (19/28) patients with IBD,
which was significantly higher as compared with the controls 36%
(12/33) (P,0.05). The C. concisus positive rates in patients with CD
and UC were 67% (10/15) and 69% (9/13) respectively; the C.
concisus positive rate between UC and controls was statistically
different (P,0.05) and the difference between CD and the controls
was not significantly different. The prevalence of the remaining
seven Campylobacter species in patients with IBD and controls was
not statistically different (Table 3).
The C. concisus positive rate in relapsed CD was 67% (4/6),
which was not significantly different as compared with the newly
diagnosed CD cases (67%, 6/9). The C. concisus positive rate in
relapsed UC was 75% (3/4), which was not significantly different
from that of the new cases (67%, 6/9).
Of the three biopsies which showed mixed sequences by
Campylobacter genus-PCR; two samples were positive and one was
negative by C. concisus PCR.
Comparison of prevalence of C. concisus in biopsies
collected from different anatomic intestinal sites of
patients with IBD and controls
Given that C. concisus was the only Campylobacter species showing
statistical difference between patients with IBD and the controls in
this study (Table 3), the prevalence of C. concisus in biopsies
collected from ileum, caecum, colon and rectum of patients with
IBD and controls was further compared and the results are shown
in Table 4. Ileal biopsies collected from patients with IBD and
controls showed similar C. concisus positivity. Caecal biopsies of
patients with UC had a low C. concisus positive rate; however it was
not statistically different from the other groups. C. concisus positive
rate of colonic biopsies of patients with IBD was 43% (12/27),
which was significantly higher compared to the controls (P,0.05).
The C. concisus positivity in colonic biopsies of patients with CD
and UC was 53% (8/15) and 31% (4/13) respectively; with
patients with CD showing a statistically significant difference when
compared to the controls (P,0.05). The C. concisus positivity in
rectal biopsies of patients with IBD was higher than that of the
controls; however it was not statistically different (Table 4).
Prevalence of C. concisus in relation to Montreal
classification of IBD
No significant differences were noted between the prevalence of
C. concisus in patients with different Montreal classifications.
Figure 1. Campylobacter genus-PCR positivity in patients with IBD (CD and UC) and controls. Four biopsies collected from each individual
were examined. A Campylobacter genus-PCR positive individual is an individual who had at least one intestinal biopsy positive for Campylobacter
genus-PCR. *Significantly different as compared with the controls (P,0.05).
doi:10.1371/journal.pone.0025417.g001
Table 3. Percentage of Campylobacter species positivity in
patients with IBD (CD and UC) and controls
@.
IBD (n=28) CD (n=15) UC (n=13)
Controls
(n=33)
C. concisus 68% (19/28)* 67% (10/15) 69% (9/13)* 36% (12/33)
C. showae 11% (3/28) 7% (1/15) 15% (2/13) 6% (2/33)
C. hominis 7% (2/28) 7% (1/15) 8% (1/13) 9% (3/33)
C. ureolyticus 10% (3/28) 13% (2/15) 8% (1/13) 6% (2/33)
C. hyointestinalis 4% (1/28) 7% (1/15) 0 3% (1/33)
C. rectus 4% (1/28) 0 8% (1/13) 0
C. jejuni 4% (1/28) 7% (1/15) 0 0
C. gracilis 7% (2/28) 7% (1/15) 8% (1/13) 0
@A specific Campylobacter species positive individual is an individual who has
at least one biopsy positive for the Campylobacter species listed in Table 3,
detected by Campylobacter genus-PCR and sequencing. *Significantly higher as
compared with the controls (P,0.05).
doi:10.1371/journal.pone.0025417.t003
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patients with IBD and controls
C. concisus was isolated from intestinal biopsies of two patients
with IBD, one patient with CD and one patient with UC. The
identity of the C. concisus isolates was confirmed by bacterial
morphology (small curved and spiral rods), Gram stain (Gram
negative) and sequence of 1200 bp 16S rRNA gene (100%
similarity to the known C. concisus in GenBank).
Sequences accession numbers
The accession numbers of the sequences of the PCR products
submitted to GenBank were JN544934-JN545008.
Discussion
This study aimed to investigate the prevalence of C. concisus in
adult patients with CD and the possible preferential colonization
sites of Campylobacter species in the human intestine; by examining
the presence of Campylobacter species in 301 intestinal biopsies
collected from 28 patients with IBD and 33 controls using PCR-
sequencing and Campylobacter cultivation.
The high positive rate of Campylobacter genus-PCR and intestinal
prevalence of C. concisus in adult patients with CD and UC
observed in this study are consistent with our previous findings in
paediatric CD and the findings by Mukhopadhya et al in adult UC
[13,14,15]. A further finding of this study is the increased
prevalence of C. concisus in the proximal large intestines
(descending colon and rectum) of patients with IBD as compared
with the controls (Table 4). In adult patients with CD, only
biopsies collected from the descending colon showed a significantly
higher prevalence of C. concisus as compared with the controls
(Table 4).
Different Campylobacter species may have preferable intestinal
colonization sites in their hosts. For example, a study from Inglis et
al examining the colonization of C. jejuni and Campylobacter lanienae
in asymptomatic beef cattle, C. jejuni was found to colonize the
proximal small intestine whereas C. lanienae was detected primarily
in the caecum, descending colon and rectum [19].
In individuals without intestinal inflammation, biopsies collected
from ileum, caecum, descending colon had a similar C. concisus
positive rate and the rectal biopsies had a lower C. concisus positive
rate (Table 2). However, in patients with IBD, a higher prevalence
of C. concisus in the proximal large intestine (descending colon and
rectum) was detected (Table 4). It is not entirely clear why C.
concisus was more prevalent in the proximal large intestine of
patients with IBD, particularly in descending colon of patients with
CD (Table 4). It is possible that this may relate to the fact that C.
concisus requires hydrogen enriched microaerophilic atmosphere
for growth [2]. In the human intestine, hydrogen is produced by
bacterial flora through fermentation of unabsorbed carbohydrates;
previous studies showing that 99% of hydrogen in the intestine is
produced in the colon [20]. The amount of hydrogen produced in
the intestine is affected by food type and intestinal bacterial
composition [20,21]. It may be that the microenvironment of
proximal large intestine in some individuals is more suitable for C.
concisus growth. Whether the high prevalence of C. concisus in the
proximal large intestine of patients with IBD is a primary event or
secondary to the disease is not known. The finding in this study
that the prevalence of C. concisus in newly diagnosed patients is
similar to that of the relapsed cases suggests that the high
prevalence of C. concisus in patients with IBD is likely a primary
event.
The finding that C. concisus has a preferable intestinal
colonization site (the proximal large intestine) in patients with
IBD suggests that different bacterial species may be associated with
IBD occurring at different parts of the gastrointestinal tract. Other
evidence from both human and animal studies supports this view.
For example, in human studies adherent and invasive Escherichia
coli has been found to be associated with ileal CD only [22].
Furthermore, antibiotics used to treat patients with IBD were
effective only in a subgroup of patients [23]. In animal studies, IL-
10
-/
- mice developed caecal inflammation when monoassociated
with E. coli but distal colitis when colonized with Enterococcus faecalis
[24].
Whether C. concisus detected in patients with IBD has
contributed to the pathogenesis of the disease requires further
investigation. C. concisus is a bacterium with great diversity; which
has been demonstrated by various research groups using different
methodologies [25,26,27,28,29]. Intestinal C. concisus strains have
been shown to be able to induce production of IL-8 in HT-29 cells
and some C. concisus strains were invasive to Caco2 cells [30,31]. In
addition, the presence of bacterial virulence factors such as
phospholipase A2 and a cytolethal distending toxin (CDT)-like
toxin in some C. concisus strains suggest that some C. concisus strains
may have the enteric pathogenic potential [32,33].
Examination of prevalence of C. concisus in patients with gum
disease by Macuch and Tanner has revealed an interesting
relationship between C. concisus and oral mucosal inflammation
[5]. In their study, Macuch and Tanner found that the isolation of
C. concisus from subgingival plaque samples of patients with initial
periodontitis was greatly higher than the controls. However the
isolation rate of C. concisus in patients with established periodontitis
was greatly reduced in comparison with the healthy controls [5].
These results suggest that C. concisus may be only associated with
mild oral mucosal inflammation. A more severe inflammatory
microenvironment such as the established periodontitis is certainly
no longer a favourable environment for C. concisus. We have
observed a similar phenomenon in patients with CD. In our
previous study in a paediatric population, we found that biopsies
taken from macroscopic normal area near the inflamed area had
higher C. concisus detection than biopsies taken from the centre of
the severely inflamed area [13]. Patients with UC included in this
study had mild to moderate disease severities (Table 1); we
therefore were unable to examine the prevalence of C. concisus in
patients with severe UC.
Table 4. Detection of C. concisus in biopsies collected from
four intestinal anatomic sites of patients with IBD (CD and UC)
and controls
@.
IBDn=28 CDn=15 UCn=13 Controln=33
Ileum 23% (6/26) 23% (3/13) 23% (3/13) 21% (7/33)
Caecum 15% (4/27) 21% (3/14) 9% (1/13) 18% (6/33)
Colon 43% (12/28)* 53% (8/15)* 31% (4/13) 18% (6/33)
Rectum 26% (7/27) 21% (3/14) 31% (4/13) 9% (3/33)
@ Identification of C. concisus was based on Campylobacter genus-PCR and
sequencing of the positive PCR products, except for three biopsy samples. The
three biopsy samples showed mixed sequences by Campylobacter genus-PCR,
therefore were further subjected to C. concisus PCR to examine the presence of
C. concisus.
Biopsies collected from four intestinal anatomic sites were examined; ileal
biopsies were not available from two patients with CD, caecal biopsy was not
available from one patient with CD and rectal biopsy was not available from
one patient with CD.
*Significantly higher in patients with IBD as compared with the controls
(P,0.05).
doi:10.1371/journal.pone.0025417.t004
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of IBD, if there is any, would be most likely to facilitate the
establishment of the inflammation in the early stage of the disease
or to promote inflammation from a mild form to a more severe
form. Recently, we found that C. concisus has the ability to
modulate the gut mucosal immune system through upregulation of
the intestinal epithelial expression of Toll-like receptor (TLR)-4
(unpublished data). The low level intestinal epithelial expression of
TLR-4 is one of the mechanisms allowing gut mucosal system to
maintain its tolerance to commensal intestinal bacteria flora [34].
Accumulated evidence suggests that some intestinal commensal
bacterial species are involved in the pathogenesis of IBD [11].
Perhaps the increased intestinal expression of TLR-4 induced by
C. concisus has upregulated responses of the gut mucosal immune
system to some intestinal commensal bacterial species otherwise it
would tolerate. This hypothesis requires further investigation.
Despite the high prevalence of C. concisus detected in patients
with IBD, the amount of C. concisus DNA in the intestinal biopsies
was generally low. An initial examination of 20 biopsies collected
from 5 patients with CD using direct Campylobacter genus-PCR
revealed low positivity. Given this, we decided to use a nested PCR
method to amplify the 16S rRNA gene of universal bacteria and
then use Campylobacter genus-PCR. The nested PCR has greatly
increased the detection rate of Campylobacter species in biopsy
samples. It is likely that the preparation procedure for colonos-
copy, which involves induction of severe diarrhoea, may have
contributed to the low number of C. concisus in the biopsies.
In addition to detection of C. concisus from intestinal biopsies by
PCR, we have isolated C. concisus from intestinal biopsies of one
patient with CD and one patient with UC.
Some other Campylobacter species detected in this study have
been shown to be clinically important. However, the prevalence of
these Campylobacter species in patients with IBD was low and not
significantly different from that in the controls (Table 3).
In summary, in this study we detected a significantly higher
prevalence of C. concisus in colonic biopsies of adult patients with
CD as compared with the controls and isolated C. concisus from
intestinal biopsies of adult patients with IBD. Furthermore, we
found that C. concisus preferentially colonizes the proximal large
intestine of patients with IBD. These results suggest that future
studies are needed to investigate the possible involvement of C.
concisus in a subgroup of human IBD. To our knowledge, this is the
first report of the association between adult CD and C. concisus; the
first study of the preferential colonization sites of C. concisus in the
human intestine; and the first isolation of C. concisus from intestinal
biopsies of adult patients with IBD.
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